SANDOZ 620 Pill - red capsule-shape, 18mm
Pill with imprint SANDOZ 620 is Red, Capsule-shape and has been identified as Rivastigmine Tartrate 4.5 mg. It is supplied by Sandoz Pharmaceuticals Inc.
Rivastigmine is used in the treatment of Alzheimer's Disease; Parkinson's Disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 4.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for SANDOZ 620
Rivastigmine Tartrate
- Imprint
- SANDOZ 620
- Strength
- 4.5 mg
- Color
- Red
- Size
- 18.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Cholinesterase inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00781-2616 (Discontinued)
- Inactive Ingredients
-
gelatin,
hypromelloses,
magnesium stearate,
microcrystalline cellulose,
ferric oxide red,
silicon dioxide,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
More about rivastigmine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (38)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: cholinesterase inhibitors
Patient resources
- Rivastigmine drug information
- Rivastigmine transdermal
- Rivastigmine (Oral) (Advanced Reading)
- Rivastigmine (Transdermal) (Advanced Reading)
- Rivastigmine Capsules
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.